Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20234618

Company浙江诺得药业有限公司

Registration Date

March 6, 2024

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg（以氨氯地平计）

Drug Type

化学药品

Registration Date

March 6, 2024

Company Information

Applicant Company

Company Name浙江诺得药业有限公司

Company Address

浙江省台州市黄岩区江口街道鑫源路8号

Manufacturing Company

Company Name浙江诺得药业有限公司

Company Address

浙江省台州市黄岩区江口街道鑫源路8号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy